Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Shenzhen Immvira Completes $58 Million Funding for Oncolytic Virus Therapies

JW Therapeutics Raises $100 Million to Support CAR-T Portfolio

Suzhou Innovent Signs $2 Billion-plus Bi-Specific/CAR-T Development Deal with Roche

Nanjing Legend Bio Completes $424 Million NASDAQ IPO; Shares Rise 60%

Nanjing Legend Biotech Plans to Raise $350 Million in US IPO at $2.6 Billion Valuation

Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China